The National Institute of Biological Imaging and Bioengineering (NIBIB) of National Institutes of Health (NIH) recently awarded more than $6.4 million for the continuation of the Bioengineering Research Partnership (BRP) Raman Flow Cytometry for Drug Discovery and Diagnostics. This multidisciplinary effort, led by LJBI Professor John Nolan, aims to extend the capabilities for multiplexed and multiparameter analysis of cells and cells systems by developing new flow cytometry instrumentation, reagents, and assays. The Partnership also includes scientists at the University of Alberta, Los Alamos National Laboratory, and Stanford University as well as several industrial partners.